HealthcareServices

Renal Insufficiency Industry Poised for Rapid Growth, Forecast to Touch $20.5 Billion by 2030 at 11.1% CAGR

March 2, 2026March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the renal insufficiency market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Renal Insufficiency Market covering 2026–2035?

The renal insufficiency market has recently experienced significant expansion. It is anticipated to increase from $12.1 billion in 2025 to $13.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.4%. This historical growth can be attributed to factors such as the rising prevalence of diabetes and hypertension, the expansion of dialysis center networks, increased utilization of ACE inhibitors and ARBs, a growing diagnosis of chronic kidney disease, and improved access to renal care services.

The renal insufficiency market size is projected to experience swift expansion in the coming years. This market is anticipated to reach a value of $20.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.1%. The growth expected during the forecast period stems from factors such as the increasing integration of home dialysis solutions, a surge in investments towards regenerative therapies, the broader implementation of digital patient monitoring, an escalating need for individualized renal treatment strategies, and a heightened emphasis on retarding disease progression. Furthermore, key trends emerging during the forecast period encompass the greater embrace of advanced dialysis methods, a heightened focus on managing the disease in its early stages, an expanding application of combination drug therapies, a wider availability of home-based treatment alternatives, and an intensified concentration on patient-centered care approaches.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21271&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Renal Insufficiency Market?

The rising incidence of high blood pressure and diabetes is anticipated to propel the expansion of the renal insufficiency market moving forward. These conditions, high blood pressure and diabetes, are linked to factors such as inadequate diet, insufficient physical activity, obesity, genetic predisposition, and an aging demographic. Hypertension damages kidney blood vessels through scarring and reduced filtration, while diabetes leads to thickened and overworked kidney vessels due to elevated blood sugar levels; both conditions accelerate kidney damage and ultimately result in renal insufficiency. For instance, in May 2024, according to the National Health Service, a UK-based government agency, the number of high blood pressure diagnoses in the South East increased by 71,120 patients in December 2023, marking a 5.4% rise compared to December 2022. Furthermore, in April 2023, the British Diabetic Association, a UK-based charity organization, reported that 4.3 million people are living with a diabetes diagnosis in the UK. Therefore, the growing number of high blood pressure and diabetes cases is driving the growth of the renal insufficiency market.

What Leading Segments Are Studied In The Renal Insufficiency Market?

The renal insufficiency market covered in this report is segmented –

1) By Treatment Type: Medications, Dialysis, Kidney Transplantation, Other Treatment Types

2) By Disease Stage: Chronic Kidney Disease (CKD) Stages, End-Stage Renal Disease (ESRD)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By End-User: Dialysis Centers, Hospital And Clinics, Research And Academic Institutes

Subsegments:

1) By Medications: Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Sodium Bicarbonate

2) By Dialysis: Hemodialysis, Peritoneal Dialysis, Home Dialysis, Continuous Renal Replacement Therapy (CRRT)

3) By Kidney Transplantation: Living Donor Kidney Transplant, Deceased Donor Kidney Transplant, Kidney Transplant Immunosuppressive Therapy

4) By Other Treatment Types: Lifestyle And Dietary Modifications, Stem Cell Therapy, Gene Therapy

Which Trends Are Shaping Activity Within The Renal Insufficiency Market?

Leading companies in the renal insufficiency market are developing glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to manage kidney and cardiovascular complications in individuals with diabetes and chronic kidney disease (CKD). These GLP-1 RAs improve glucose regulation, decrease inflammation, and reduce oxidative stress within the kidneys, thereby slowing the advancement of renal insufficiency. For example, in January 2025, Novo Nordisk, a Denmark-based pharmaceutical company, received Food and Drug Administration (FDA) approval for its Ozempic (semaglutide) to mitigate the risk of kidney disease worsening, kidney failure, and cardiovascular death in adults suffering from type 2 diabetes and chronic kidney disease (CKD). This approval underscores the increasing importance of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as a combined treatment strategy for both diabetes and renal insufficiency, addressing significant unmet medical needs in patients with progressive CKD.

Which Key Players Are Driving Competition In The Renal Insufficiency Market?

Major companies operating in the renal insufficiency market are Kaiser Permanente, Johnson & Johnson, Roche Holding AG, Sanofi S.A., Abbott Laboratories, Medtronic plc, Amgen Inc., Asahi Kasei Medical Co. Ltd., Fujifilm Holdings Corporation, Fresenius Medical Care, Toray Industries Inc., Baxter International Inc., Boehringer Ingelheim, DaVita Inc., Eisai Co. Ltd., Nipro Corporation, Biocon Limited, HemoCue AB, Rockwell Medical, Mitsubishi Tanabe Pharma Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/renal-insufficiency-global-market-report

Which Region Is Projected To Lead The Renal Insufficiency Market During The Forecast Period?

North America was the largest region in the renal insufficiency market in 2025. The regions covered in the renal insufficiency market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Renal Insufficiency Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21271&type=smp

Browse Through More Reports Similar to the Global Renal Insufficiency Market 2026, By The Business Research Company

Rare Kidney Diseases Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Kidney Dialysis Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-dialysis-global-market-report

Chronic Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795